Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-01-09
2007-01-09
Spivack, Phyllis G. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S306000, C514S450000, C514S221000
Reexamination Certificate
active
10285277
ABSTRACT:
The present invention relates to pharmacological methods for the amelioration of sleep-related breathing disorders via administration of agents or combinations of agents that possess serotonin-related pharmacological activity.
REFERENCES:
patent: 5075290 (1991-12-01), Findley et al.
patent: 5082665 (1992-01-01), Verny
patent: 5166158 (1992-11-01), Zimmerman et al.
patent: 5356934 (1994-10-01), Robertson et al.
patent: 5612379 (1997-03-01), Laurent
patent: 6030992 (2000-02-01), Gitter et al.
patent: 6071928 (2000-06-01), Curtis et al.
patent: 6143792 (2000-11-01), Cattelin
patent: 6303595 (2001-10-01), Andrews
patent: 6432956 (2002-08-01), Dement et al.
patent: 6548082 (2003-04-01), Rubin et al.
patent: 6649183 (2003-11-01), Rubin et al.
patent: 2003/0130266 (2003-07-01), Radulovacki
patent: 0 442 423 (1991-08-01), None
patent: 0 442 424 (1991-08-01), None
patent: 0 518 767 (1992-12-01), None
patent: WO 99/00119 (1999-01-01), None
patent: WO 99/25356 (1999-05-01), None
patent: WO 99/43319 (1999-09-01), None
patent: WO 99/65490 (1999-12-01), None
patent: WO 99/65571 (1999-12-01), None
patent: WO 00/51582 (2000-09-01), None
patent: WO 02/36113 (2002-05-01), None
Armstrong et al.,J. Physiol.(Lond.), 365:104 P (1985).
Badr et al.,Am. J. Respir. Crit. Care Med., 150:561-564(1994).
Bennington et al.,Sleep, 17:28-36 (1994).
Bisgard et al.,Resp. Physiol., 37:61-80 (1979).
Black et al.,Am. J. Physiol., 223:1097-1102 (1972).
Butler et al.,Br. J. Pharmacol., 94:397-412 (1988).
Carley et al.,Physiol. Behav., 59:827-831 (1996).
Carley et al.,Sleep, 19:363-366 (1996).
Christon et al.,J. Appl. Physiol., 80:2102-2107 (1996).
Coon, R.L.,J. Appl. Physiol., 76:2546-2551 (1994).
deBoer, Th.,J. Clin. Psychiatr., 57(4):19-25 (1996).
Devane, C.,J. Clin. Psychiatry., 59(20):85-93 (1998).
Douglas et al.,Sleep, 23:S147-149(2000).
Downs et al.,Laryngoscope, 105:857-861(1995).
Goda et al.,European J. Pharmacology, 183/3:705-706 (1990).
Greulich et al.,Schlafverhalten Bei Patienten Mit Morbus Parkinson Somnologie, 2:163-171 (1998).
Grogaard et al.,Pediatr. Res., 17:213-219(1983).
Hagan et al.,Eur. J. Pharmacol., 138:303-305 (1987).
Hanzel et al.,Chest., 100:416-421 (1991).
Hilaire et al.,J. Physiol., 466:367-382 (1993).
Hudgel et al.,Am. J. Respir. Crit. Care Med., 152:186-192 (1995).
Hudgel,J. Lab. Clin. Med., 126:13-18 (1995).
Jacobs et al.,Circ. Res., 29:145-155 (1971).
Kraiczi et al.,Sleep, 22:61-67 (1999).
Kubin et al.,Neurosci. Lett., 139:243-248 (1992).
Mancia et al., In: Orem et al., eds., “Physiology in sleep,” Academic Press, New York, NY, pp. 1-55 (1980).
McQueen et al.,J. Physiol., 5073:843-855 (1998).
Mendelson et al.,Am. Rev. Respir. Dis., 141:1527-1530 (1990).
Mendelson et al.,J. Clin. Psychopharmacol., 11:71-72 (1991).
Mendelson et al.,Physiol. Behav., 43:229-234 (1988).
Morin,Neurosci. Lett., 160:61-64 (1993).
Monti et al.,Pharmacol. Biochem. Behav., 53:341-345 (1996).
Monti, et al.,Pharmacol. Biochem. Behav., 51(1):125-131 (1995).
Orem et al.,Respir. Physiol., 30:265-289 (1977).
Phillipson, E.,Annu. Rev. Physiol., 40:133-156 (1978).
Planes et al.,Sleep, 22:507-513(1999).
Ponsonby et al.,J. Paediatr. Child Health, 33:317-323(1997).
Puzantian,Am. J. Health-Syst. Pharm., 55:44-49 (1998).
Radulovacki et al.,J. Pharm. Exp. Ther., 228(2):268-274 (1984).
Radulovacki et al.,Sleep, 21(2):131-136 (Mar. 1998).
Radulovacki et al.,Sleep, 19:767-773 (1996).
Rose et al.,Resp.. Physiol., 101:59-69 (1995).
Sampson et al.,Life Sci., 15:2157-2165 (1975).
Sanders-Bush et al., 5-Hydroxytryptamine (Serotonin) Receptor Agonist and Antagonist, Chapter 11, pp. 249-263.
Sapru et al.,Res. Comm. Chem. Pathol. Pharmacol., 16:245-250 (1977).
Sato et al.,Am. J. Physiol., 259:R282-R287 (1990).
Schmidt, Bull.Eur. Physiol. Respir., 19:625-629 (1982).
Sieck et al.,Exp. Neurol., 67:79-102 (1980).
Sullivan, In: Orems et al., eds., “Physiology in sleep,” Academic Press, New York, NY, pp. 213-272 (1980).
Szereda-Przastaszewska et al.,Respir. Physiol., 101:231-237 (1995).
Thomas et al.,J. Appl. Physiol., 78:1215-1218 (1992).
Thomas et al.,J. Appl. Physiol., 73:1530-1536 (1995).
Veasey et al.,Sleep Res., A529 (1997).
Veasey et al.,Am. J. Resp. Crit. Care Med., 153(2):776-786 (1996).
Wilken et al.,Pediatr., 130:89-94 (1997).
Yoshioka et al.,Res. Comm. Chem. Pathol. Pharmacol., 74:39-45 (1991).
Yoshioka et al.,J. Pharmacol. Exp. Ther., 260(2):917-924 (Jan. 1992).
Yoshioka et al.,J. Pharmacol. Exp. Ther., 250:637-641 (1989).
Zucker et al.,Circ. Res., 47: 509-515 (1980).
Hudgel et al.,J. Appl. Physiol., 56:13-17 (1984).
Matsumoto,Arch. Int Pharmacodyn. Ther., 254:282-292 (1981).
Sutton,Pfllugers Arch., 389:181-187 (1981).
G.H. Xiao et al.,Gastroenterology, vol. 114, No. 4, Part 2, p. A336 (1998).
S.M. Harding,American Journal of the Medical Sciences, vol. 315, No. 6, pp. 367-376 (1998).
S.V. Sobel et al.,The American Journal of Psychiatry, United States, vol. 142, No. 6, pp. 775-776 (1985).
Y. Vandenplas,European Journal of Gastroenterology Hepatology, vol. 10, No. 10, pp. 871-881 (1998).
Carley David W.
Radulovacki Miodrag
Board of Trustees of The University of Illinois
Marshall & Gerstein & Borun LLP
Spivack Phyllis G.
LandOfFree
Pharmacological treatment for sleep apnea does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmacological treatment for sleep apnea, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmacological treatment for sleep apnea will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3767029